KRISTY HEBERT: Open Payments
NPI 1073989224 · GRAY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 19 payments from 13 companies in 2025. Trend: 2023 $706 · 2024 $356 · 2025 $499
Food & beverage: $439Education: $60
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $104 |
| Novo Nordisk Inc | 4 | $83 |
| Astellas Pharma US Inc | 1 | $60 |
| Lilly USA, LLC | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $33 |
| Alkermes, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
Products named: CAPLYTA, Ozempic, REXULTI, MOUNJARO, FANAPT, VRAYLAR, ARISTADA, The Cologuard Plus Collection Kit.
Industry payments across LA — which companies pay providers there.
